Products

Products

Home page

Intermediates

7,8,9,10-Tetrahydro-8-(trifluoroacetyl)-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine

6,6-Dimethyl-3-azabicyclo[3.1.0]hexane

3-Fluoro-5-hydroxybenzonitrile

[1,2,4]Triazolo[1,5-a]pyridin-7-ol

1H-Indazole-7-carboxylic Acid

N-Tert-butyl-1H-indazole-7-carboxamide

Dimorpholinophosphinyl Chloride

Fmoc-L-glutamicacidgamma-methylester

2-(2-Amino-5-bromobenzoyl)pyridine

4-Methylidenepiperidine, Hydrochloride

1-(((2R,3S)-2-(2,4-Difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole

(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol

(R)-2-((4-Nitrophenethyl)amino)-1-phenylethanol Hydrochloride

(R)-(+)-1-(1-Naphthyl)ethylamine

N-((R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)-propanamide

(R)-(+)-1-Phenylethanol

(S)-(-)-1-Phenylethanol

Pyridine-2-sulfonyl fluoride

< 1 2 3 >

News Center

Viwit Pharmaceuticals' Sterile Production Facility Successfully Passes U.S. FDA Inspection

Viwit Pharmaceutical's Phenylephrine Hydrochloride Injection Officially Receives Official Approval by China NMPA

Viwit Pharmaceuticals’ Brimonidine tartrate and Timolol maleate eye drops receive Official Approval by China NMPA

Viwit's Nitroglycerin Sublingual Tablets Approved by FDA

Viwit Pharmaceuticals API Site Successfully Passed FDA cGMP On-site Audit with "No Action Indicated"

Viwit Pharmaceutical Co. Ltd. announces exclusive licensing and supply agreement for two Gadolinium based Magnetic Resonance Imaging (MRI) injectable contrast agents in the US.

← Back to previous page

(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol

Product Name:

(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol

CAS#:

133775-25-4

VIWIT

Technical Support:China Enterprise Cross-border | SEO Tags

【Business License】

Search